Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sexually transmitted infections: challenges ahead.

Magnus Unemo1, Catriona S Bradshaw2, Jane S Hocking3

  • 1WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

The Lancet. Infectious Diseases
|July 14, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-reported vaccine uptake across six infectious diseases among gay, bisexual, transgender, and non-binary individuals in Australia: findings from a 2024 national survey.

Sexual health·2026
Same author

Declining efficacy of moxifloxacin for Mycoplasma genitalium infection: time for fluoroquinolone-resistance guided therapy?

The Journal of infectious diseases·2026
Same author

Awareness, Usage and Perceptions of Doxycycline Post-Exposure Prophylaxis (doxyPEP) for Prevention of Sexually Transmitted Infections in Australia: Insights From a National Cross-Sectional Survey.

The Medical journal of Australia·2026
Same author

Asymptomatic Screening for Neisseria gonorrhoeae Among Gay and Bisexual Men Attending Public Sexual Health Services in Australia and Associations With Patterns of Ceftriaxone Consumption: A Retrospective Observational Study.

The Journal of infectious diseases·2026
Same author

Consensus recommendations for testing of <i>Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis</i>, and <i>Mycoplasma genitalium</i> infections in the Asia-Pacific (APAC)-modified Delphi method.

International journal of STD & AIDS·2026
Same author

Bacterial vaginosis and vulvovaginal candidiasis: sexual and contraceptive practices drive positivity and recurrent infections.

Sexually transmitted infections·2026

Sexually transmitted infections (STIs) like chlamydia and gonorrhoea affect nearly 1 million daily worldwide. This review highlights challenges and new strategies for STI treatment and control, focusing on antimicrobial resistance and improved case management.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Globally, nearly 1 million new sexually transmitted infections (STIs) occur daily, yet research remains underfunded.
  • Common STIs include chlamydia, gonorrhoea, syphilis, and trichomoniasis, posing significant public health challenges.
  • Antimicrobial resistance in gonorrhoea and recurrent bacterial vaginosis are growing concerns.

Purpose of the Study:

  • To address key challenges in STI treatment and control.
  • To explore novel strategies for managing common STIs, including chlamydia and gonorrhoea.
  • To improve understanding and clinical management of STIs, particularly in vulnerable populations.

Main Methods:

  • Review of current literature and data on STI prevalence, treatment, and control strategies.

Related Experiment Videos

  • Analysis of challenges in managing specific STIs like chlamydia and bacterial vaginosis.
  • Examination of emerging issues such as antimicrobial resistance and point-of-care diagnostics.

    • Main Results:

    • Chlamydia control requires shifting focus from screening to managing diagnosed cases and morbidity.
    • Antimicrobial resistance in Neisseria gonorrhoeae necessitates development of novel treatments.
    • Bacterial vaginosis recurrence may be linked to sexual transmission, impacting management approaches.
    • Point-of-care tests show promise for improving STI case management in low-resource settings.
    • Increased STI rates in men who have sex with men are discussed in context of HIV prevention strategies.

    Conclusions:

    • Effective STI control requires innovative approaches beyond traditional screening.
    • Addressing antimicrobial resistance and understanding transmission dynamics are crucial for future treatments.
    • Point-of-care diagnostics and tailored public health strategies can enhance STI management globally.